DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma.

Information source: Liaoning University of Traditional Chinese Medicine
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Bronchial Asthma

Intervention: warming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum (Other); clearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrum (Other); securing origin and relieving asthmatic granule and securing origin and nourishing lung emplastrum (Other); Theophylline Sustained-release Tablets and budesonide suspension (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: Liaoning University of Traditional Chinese Medicine


Bronchial asthma is a common disease and frequently encountered disease of respiratory apparatus. It has very complex mechanism and multiple inducing factors. This study will focus on a new Chinese therapy on Bronchial asthma, analyzing the treatment mechanism of internal and external use, based on Traditional Chinese Medicine (TCM) theory and clinical practice. The study will also investigate the efficacy of the Chinese drugs and treatments on Bronchial asthma, and provide an effective therapy for this disease.

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome:

primary Symptom

physical sign

assistant examination

Secondary outcome:

Secondary Symptom

physical sign


Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.


Inclusion Criteria:

- Age between 18 to 65 years old;

- Patients with mild-to-moderate bronchial asthma on attacking stage;

- Without cardiopulmonary or other complications;

- To comply with the diagnostic standard of bronchial asthma in western medicine and

TCM syndrome differentiation;

- Informed consent form is required to be signed.

Exclusion Criteria:

- Older than 65 years or younger than 18 years old;

- Pregnant woman or suckling period woman;

- Patients combine serious primary disease in liver, renal, cardiovascular and

cerebrovascular, hemopoietic system diseases,or psychosis.

- Severe levels of disease is between severe and critical extent. Combine Pulmonary

Heart Disease or respiratory failure;

- Irritable the physique, or allergic to the given composition of drugs in this


- Patients who are in the process of other clinical research.

Locations and Contacts

Additional Information

Starting date: December 2008
Last updated: February 10, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017